PepLabo Download

Zepbound® and dry mouth

Dry mouth on Zepbound®: 1% vs 0.1% on placebo in the US label, dose-by-dose Canadian data, the dehydration link, other causes and when to call.

Published · Updated · Zepbound®: side effects by symptom · Written by the PepLabo editorial team

When to get help
Context and scope

A sticky, dry mouth on waking, or a throat that feels parched even after a drink, is a complaint some people link to Zepbound®. Unlike many symptoms people search for, this one is actually recorded in Zepbound®’s US and Canadian documents, though it is uncommon. The more important point is what dry mouth can signal: fluid loss from stomach side effects, which the label treats seriously. This page covers both.

Key takeaways 5
  • The US label reports dry mouth or dry throat in 1% of people on Zepbound® versus 0.1% on placebo in its two main weight trials. [1]
  • The Canadian table gives 0.8%, 1.2% and 0.7% at 5, 10 and 15 mg versus 0.1% on placebo, so it did not climb with dose. [3]
  • Dry mouth appears among possible side effects in the Canadian patient information, but not in the EU tirzepatide table. [3][4]
  • The label warns that vomiting and diarrhea can lead to dehydration and kidney injury; a dry or sticky mouth is an early dehydration sign. [1][10]
  • Dry mouth is also a recognised symptom of sleep apnea, one of Zepbound®’s two approved uses. [7]

The numbers behind the dry mouth paragraph

Zepbound®’s main US side-effect table admits only reactions reported by at least 2% of people on Zepbound® and more often than placebo. Dry mouth falls below that line, so it sits in a short separate paragraph of section 6.1: in the pooled SURMOUNT-1 and SURMOUNT-2 trials, a dry mouth or dry throat affected 1% of people on Zepbound® against 0.1% on placebo. [1] The Canadian monograph places the same finding in its main table because it uses a 1% threshold, and it breaks the figure down by dose. [3]

Dry mouth in Zepbound® / tirzepatide product information (checked 20-10-2026)
Source and populationZepbound®PlaceboNotes
US label §6.1, SURMOUNT-1 and -2, all doses pooled [1]1%0.1%Reported as “dry mouth or dry throat”
Canadian monograph, Table 2: 5 / 10 / 15 mg [3]5 (0.8%) / 11 (1.2%) / 7 (0.7%) patients1 (0.1%)Listed under gastrointestinal disorders
Canadian patient information [3]Listed—Among “possible side effects”
EU, tirzepatide sold as Mounjaro® [4]Not listed—No Zepbound® EPAR exists
US Medication Guide [2]Not named—Asks you to drink fluids to reduce dehydration

What research has looked at

There are no dedicated trials of dry mouth with tirzepatide. A 2026 review of oral and salivary effects of GLP-1 medicines and tirzepatide gathered case reports, spontaneous reports and laboratory work, and described dry mouth, reduced saliva, taste changes and burning or throat discomfort among reported problems. [5] It proposed three possible routes: a direct effect on signalling in the salivary glands, altered nerve control of saliva, and dehydration from stomach side effects. The authors stressed that the evidence is limited and mostly indirect. [5]

An analysis of ear, nose and throat reports in the FDA’s spontaneous reporting system covered five GLP-1 medicines including tirzepatide. Its abstract reports a dry mouth signal for semaglutide but does not name one for tirzepatide. [6] Reporting systems cannot show cause or frequency, and tirzepatide had been on the market for a shorter time than the others.

Fluid loss: the reason dry mouth matters

Gastrointestinal reactions were the most common Zepbound® side effects, reported by 56% at each dose versus 30% on placebo, and most nausea, vomiting and diarrhea happened while the dose was being raised. [1] The label’s warning on acute kidney injury explains that such losses can lead to dehydration, and asks clinicians to watch kidney function especially when starting and stepping up the dose. [1]

MedlinePlus lists a dry or sticky mouth alongside thirst, passing less urine, darker yellow urine, headache and muscle cramps as signs of mild to moderate dehydration. [10] The Canadian patient information describes dehydration that needs a clinician as dark yellow, strong-smelling urine, extreme thirst and feeling dizzy or light-headed. [3] So a dry mouth in a week with vomiting or diarrhea deserves more attention than one on an ordinary day.

Other things that dry the mouth

The National Institute of Dental and Craniofacial Research notes that hundreds of medicines can reduce saliva, including some for high blood pressure, depression and bladder control. It also names diseases such as diabetes and Sjögren’s disease, cancer treatment and nerve damage. [9] Feeling nervous or stressed can dry the mouth temporarily. [9]

Two causes are worth checking in people who use Zepbound®. High blood sugar in diabetes can cause strong thirst and a dry mouth, [11] which is relevant for those with type 2 diabetes, as in SURMOUNT-2. And sleep apnea, for which Zepbound® is approved in adults with obesity, lists dry mouth among its symptoms, so a dry mouth on waking may point to sleep rather than to the injection. [1][7]

Relief steps from health agencies

MedlinePlus suggests sipping water or a sugar-free drink with meals, chewing sugar-free gum or sucking sugar-free hard sweets to stimulate saliva, limiting caffeinated drinks, which can dry the mouth, and avoiding tobacco and alcohol. [8] It also notes that spicy or salty food can sting a dry mouth. [8]

Saliva protects the teeth, and a persistently dry mouth raises the risk of tooth decay and mouth infections, according to the National Institute of Dental and Craniofacial Research; it advises good oral care and regular dental check-ups. [9] If another medicine is the likely cause, your doctor or dentist may consider alternatives or a saliva substitute; [9] do not change any medicine on your own.

Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.

When to get help

The signs and contact information below come from this article’s sourced guidance.

Emergency

  • Swelling of the tongue, lips, face or throat, or trouble breathing or swallowing

    Contact: Stop Zepbound® and get emergency help (911 or local number)

    Medication Guide [2]

  • Very dark or amber urine or no urine, confusion, a racing heart or fainting

    Contact: Emergency care (severe dehydration)

    MedlinePlus [10]

Today

  • Dry mouth with ongoing vomiting or diarrhea, extreme thirst or feeling light-headed

    Contact: Your prescriber, the same day

    Medication Guide [2]; Canadian patient information [3]

  • Strong thirst and dry mouth with high glucose readings if you have diabetes

    Contact: Contact your diabetes care team

    MedlinePlus [11]

At your next appointment

  • A dry mouth that persists for weeks, mouth sores or trouble chewing and swallowing

    Contact: Your dentist or doctor

    NIDCR [9]

Questions

Does Zepbound® cause dry mouth?

It is recorded but uncommon: 1% on Zepbound® versus 0.1% on placebo in the US label, and 0.7–1.2% by dose in the Canadian monograph. [1][3]

Is dry mouth worse on a higher Zepbound® dose?

The Canadian figures do not show a dose pattern: 0.8% at 5 mg, 1.2% at 10 mg and 0.7% at 15 mg. [3] The US label gives only a pooled figure. [1]

Does a dry mouth mean I am dehydrated?

Not always, but it is one early sign. MedlinePlus lists it with thirst, less urine, darker urine and headache. [10] If you have also had vomiting or diarrhea, contact your prescriber. [2]

I wake with a dry mouth. Could it be my sleep apnea?

Possibly. Dry mouth is a recognised sleep apnea symptom, [7] and Zepbound® is approved for moderate to severe sleep apnea in adults with obesity. [1] Mention it to your sleep clinician.

Can I use sugar-free gum or lozenges?

MedlinePlus lists sugar-free gum and sugar-free hard sweets as ways to stimulate saliva, and notes some contain xylitol, which may help prevent cavities. [8]

Could dry mouth on Zepbound® affect my teeth?

Persistent dry mouth raises the risk of tooth decay and mouth infections. [9] A 2026 review adds that acid from reflux or vomiting, combined with less saliva, may make tooth erosion more likely, though a direct link to these medicines is unproven. [5] Keep regular dental visits.

Sources

Sources checked on

  1. ZEPBOUND® (tirzepatide) Prescribing Information, Eli Lilly and Company Revised 08/2026. Sections 1, 5.3, 6.1 (Table 1, gastrointestinal reactions, dry mouth) and 7.2.
  2. ZEPBOUND® (tirzepatide) Medication Guide, Eli Lilly and Company Revised 08/2026.
  3. ZEPBOUND® (tirzepatide injection) Product Monograph, Eli Lilly Canada Inc. Date of authorization 2026-06-11. Section 8.2 (Table 2); patient medication information.
  4. Mounjaro (tirzepatide): EPAR – Product Information, European Medicines Agency Section 4.8, Table 1. No Zepbound® EPAR exists; tirzepatide is authorised in the EU as Mounjaro®.
  5. Gilligan G et al. Adverse oral and salivary effects associated with glucagon-like peptide-1 receptor agonists: clinical insights. J Oral Pathol Med 2026 Narrative synthesis; PubMed abstract.
  6. Khan FI et al. Otolaryngologic side effects of GLP-1 receptor agonists. Laryngoscope 2025 FAERS disproportionality analysis; PubMed abstract.
  7. Sleep Apnea: Symptoms, National Heart, Lung, and Blood Institute (NIH)
  8. Dry Mouth, MedlinePlus (U.S. National Library of Medicine)
  9. Dry Mouth, National Institute of Dental and Craniofacial Research (NIH)
  10. Dehydration, MedlinePlus Medical Encyclopedia
  11. High blood sugar – self-care, MedlinePlus Medical Encyclopedia

Keep exploring